Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2012
11/15/2012WO2012028524A3 Method for producing a tetranectin-apolipoprotein a-i lipid particle, the lipid particle itself and its use
11/15/2012US20120289614 Functionalized biodegradable triclosan monomers and oligomers for controlled release
11/15/2012US20120289613 Emulsions, compositions and devices including graphene oxide, and methods for using same
11/15/2012US20120289612 Composite Material and Method for Producing the Same
11/15/2012US20120289611 Pectin compounds, methods of using pectin compounds, and methods of controlling water solubility
11/15/2012US20120289610 Oil gel
11/15/2012US20120289609 Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
11/15/2012US20120289608 Bone cement and a method for producing same
11/15/2012US20120289601 Gastric Retained Gabapentin Dosage Form
11/15/2012US20120289559 Method for producing fine powder and the fine powder produced by the same
11/15/2012US20120289536 Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide
11/15/2012US20120289535 Dual phase drug release system
11/15/2012US20120289516 Methods for Administering Aripiprazole
11/15/2012US20120289490 Compositions and methods for enhancing corticosteroid delivery
11/15/2012US20120289480 Cyclodextrin-based polymers for therapeutics delivery
11/15/2012US20120289470 Transmucosal administration of drug compositions for treating and preventing disorders in animals
11/15/2012US20120289469 Methods and compositions for maintaining active agents in intra-articular spaces
11/15/2012US20120288566 Liquid precursor compositions and uses thereof for a ph-dependant sustained release treatment of oral disorders
11/15/2012US20120288565 Tamper-resistant oral opioid agonist formulations
11/15/2012US20120288562 Acid Resistant Capsules
11/15/2012US20120288561 Delayed-release formulation for reducing the frequency of urination and method of use thereof
11/15/2012US20120288559 Organic compounds
11/15/2012US20120288557 Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine
11/15/2012US20120288542 Solid pharmaceutical dispersions with enhanced bioavailability
11/15/2012US20120288540 Niosomes, freeze-dried powder thereof and their use in treatment
11/15/2012US20120288537 Active self-healing biomaterial system
11/15/2012US20120288529 Pharmaceutical excipient, method for its preparation and use thereof
11/15/2012US20120288528 Mono-and disaccharide derivatives
11/15/2012US20120288512 Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders
11/15/2012US20120288491 Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
11/15/2012US20120288487 Biodegradable paox polymer particle with cationic property
11/15/2012US20120288446 Organophosphorous & multivalent metal compound compositions & methods
11/15/2012US20120288441 Injectable biodegradable particles
11/15/2012CA2848173A1 Ceramide anionic liposome compositions
11/15/2012CA2839264A1 Formulations of phospholipid comprising omega fatty acids
11/15/2012CA2835684A1 Antifungal compositions for the treatment of skin and nails
11/15/2012CA2835595A1 Non-aqueous patch
11/15/2012CA2835576A1 Protein-active agent conjugates and method for preparing the same
11/15/2012CA2835298A1 Pretargeting kit for imaging or therapy comprising a trans - cyclooctene dienophile and a diene
11/15/2012CA2835214A1 Integrin receptor antagonists and their methods of use
11/15/2012CA2835203A1 Compositions and methods for treating cancer
11/15/2012CA2834918A1 Liposomes comprising polymer-conjugated lipids and related uses
11/14/2012EP2522369A1 Pretargeting kit, method and agents used therein
11/14/2012EP2522367A1 Oligomer-protease inhibitor conjugates
11/14/2012EP2522366A1 Targeting agent for tumor site
11/14/2012EP2522365A1 Compositions comprising azelastine and methods of use thereof
11/14/2012EP2522348A1 Atrovastatin-containing coated preparation
11/14/2012EP2522337A2 Hyaluronic acid esters, their preparation and use in dermatology
11/14/2012EP2522234A2 Dietary fiber composition comprising glucomannan, xanthan gum and alginate
11/14/2012EP2522233A2 Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
11/14/2012EP2521570A2 Gastroretentive solid oral dosage forms with swellable hydrophilic polymer
11/14/2012EP2521565A1 Biomatrices to attract and retain regenerative and reparative cells
11/14/2012EP2521547A2 Methods and compositions for applying moxifloxacin to the ear
11/14/2012EP2521540A2 Solid oral dosage form containing olmesartan medoxomil
11/14/2012EP2521535A2 Biomaterials made from human hair
11/14/2012CN1978536B Novel material forming supramolecular structures, process and uses
11/14/2012CN1960707B Liposomal assembly for therapeutic and/or diagnostic use
11/14/2012CN1821313B Zinc-ferrit pigments stable against reduction, method for making and use of said pigments
11/14/2012CN1668721B Immunoadhesin comprising a glycoprotein VI domain
11/14/2012CN1434795B Acyl pseudodipeptides which carry a functionalised auxiliary arm
11/14/2012CN1338947B Novel mucosal delivery system
11/14/2012CN102781965A Compositions and methods for the transport of therapeutic agents
11/14/2012CN102781478A Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
11/14/2012CN102781477A Coating fat composition and particulate composition using same
11/14/2012CN102781476A Methods for improving oral delivery
11/14/2012CN102781475A Pharmaceutical composition and preparation for oral administration
11/14/2012CN102781474A Compositions comprising pigment particles entrapped in collapsed polymeric microspheres, and methods of making the same
11/14/2012CN102781473A Pharmaceutical composition for external use
11/14/2012CN102781472A Radiation therapy agent
11/14/2012CN102781464A Biomatrices to attract and retain regenerative and reparative cells
11/14/2012CN102781463A Methods and compositions for skin regeneration
11/14/2012CN102781429A Melt-coated pharmaceutical forms
11/14/2012CN102781428A Method and apparatus for preparing novel liposome
11/14/2012CN102781427A Easy-disintegrating polymeric micelle composition
11/14/2012CN102781425A Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
11/14/2012CN102775530A RAFT (reversible addition fragmentation chain transfer) preparation method of polylysine derivative
11/14/2012CN102775515A Amphiphilic chitosan derivatives, and preparation method and application thereof
11/14/2012CN102775514A Hyaluronic acid esters, their preparation and use in dermatology
11/14/2012CN102775502A Alpha-interferon fusion protein
11/14/2012CN102775501A Interleukin 21 (IL-21) medicine for cancer therapy
11/14/2012CN102775500A Chimeric antigen receptor iRGD-scFv (G250)-CD8-CD28-CD137-CD3zeta and application thereof
11/14/2012CN102775496A Composite medicine for targeted elimination of HIV/SIV
11/14/2012CN102775487A Artificial targeted fusion protein and protein conjugate, and preparation method and application thereof
11/14/2012CN102775472A Aprotinin and analogue as carriers across the blood-brain barrier
11/14/2012CN102775408A Stable amorphous 5-methyltetrahydrofolate salt and preparation method thereof
11/14/2012CN102772828A Self-regulation high-drug load nano-fiber drug slow-release membrane and preparation method thereof
11/14/2012CN102772802A Oleanolic acid nanoliposome modified by chitosan and polyethylene glycol and preparation method thereof
11/14/2012CN102772801A Wound spray for treating bruises and preparation method of wound spray
11/14/2012CN102772789A Pharmaceutical application of PEG-modified recombinant humanized catalase
11/14/2012CN102772787A Stable formulations of insulinoptropic peptides
11/14/2012CN102772786A Application of BMP2/7 slow release system in glioma treatment
11/14/2012CN102772715A Microelement-released anion anti-mite and anti-electromagnetic wave nanometer silver-selenium-germanium-rich snake oil ointment
11/14/2012CN102772591A Hollow, ventilation and double-layer traditional Chinese medicine suppository for treating rhinitis and production method of traditional Chinese medicine suppository
11/14/2012CN102772583A Heat clearing tablet and preparation method thereof
11/14/2012CN102772545A Yanning sugar-free granules and preparation method thereof
11/14/2012CN102772482A Sophora alopecuroide total alkali capsule and method for preparing same
11/14/2012CN102772455A Seabuckthorn flavone dispersible tablets
11/14/2012CN102772454A Brucea javanica oil dry emulsion capsule and preparation method thereof
11/14/2012CN102772428A Oral disinfectant antibacterial gargle
11/14/2012CN102772426A Medical applications of chitosan serving as component of parturition assistant lubricating agent
1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 1712